A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer

Gastric Cancer Stage III Clinical Trial

Official title:
A Study to Evaluate Camrelizumab in Combination With Docetaxel +S-1 Sequenced by Camrelizumab+S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer (PD-L1 + / MSI-H / EBV +/dMMR)

Status Recruiting

Clinical Trial Summary

To evaluate the efficacy and safety of Camrelizumab in Combination With Docetaxel +S-1 Sequenced by Camrelizumab+S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer (PD-L1 + / MSI-H / EBV +/dMMR) . Secondary study objective: To observe and evaluate the overall survival and adverse events of Camrelizumab in Combination With Docetaxel +S-1 Sequenced by Camrelizumab+S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer (PD-L1 + / MSI-H / EBV +/dMMR). To evaluate the safety ofCamrelizumab in Combination With Docetaxel +S-1 Sequenced by Camrelizumab+S-1 as Adjuvant Treatment Therapy in Stage III Gastric Cancer (PD-L1 + / MSI-H / EBV +/dMMR). Objective: To explore the incidence of PD-L1 + / MSI-H / EBV + /dMMR in stage III gastric cancer. To explore the correlation of PD-L1 + / MSI-H / EBV + /dMMR in stage III gastric cancer.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04152889
Study type	Interventional
Source	RenJi Hospital
Contact	Gang Zhao
Phone	0086-021-68383731
Email	zhaogang74313@aliyun.com
Status	Recruiting
Phase	Phase 2
Start date	April 14, 2020
Completion date	December 2022

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT04515615` - Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02)	Phase 2
Recruiting	`NCT04119622` - Toripalimab Combined With Chemotherapy as Neoadjuvant Treatment of Gastric Cancer	Phase 2
Recruiting	`NCT02969148` - Laparoscopic Bursectomy and D2 Lymphadenectomy vs.Laparoscopic D2 Lymphadenectomy in Advanced Gastric Cancer	N/A
Completed	`NCT03550482` - Oncoxin® and Quality of Life in Cancer Patients	Phase 4
Recruiting	`NCT06342427` - Stomach Cancer Exosome-based Detection
Recruiting	`NCT06042998` - A Multicenter, RCT Study of the Clinical Efficacy of Robotic and Laparoscopic Gastrectomy in Neoadjuvant Gastric Cancer	N/A
Recruiting	`NCT03788226` - A Randomized Phase III Study Comparing POF With SOX/CAPOX/FOLFOX as a Postoperative Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer	Phase 3